Dr. Yu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
435 Lewis Avenue
Meriden, CT 06451Phone+1 203-694-8200
Summary
- I am a physician leader in oncology with expertise in informatics. I am Past President of the American Society of Clinical Oncology (ASCO), a professional society of over 45,000 oncologists from more than 100 countries. My current position is Physician-in-Chief of the Hartford HealthCare Cancer Institute which cares for a third of the population in Connecticut and Clinical Member of Memorial Sloan Kettering Cancer Center. My involvement in medical informatics includes public policy, implementation of data architecture systems, interoperability of digital health and data science. I serve as Associate Editor of JCO Clinical Cancer Informatics and on the Board of Governors of ASCO CancerLinQ. I have been elected three times to serve on the Epic Systems Adult Oncology Steering Board.
Education & Training
- Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 1987 - 1989
- Icahn School of Medicine at Mount Sinai/Morningside/WestResidency, Internal Medicine, 1985 - 1986
- Icahn School of Medicine at Mount SinaiFellowship, Hematology and Medical Oncology, 1983 - 1985
- Icahn School of Medicine at Mount Sinai/Morningside/WestResidency, Internal Medicine, 1980 - 1983
- The Warren Alpert Medical School of Brown UniversityClass of 1980
Certifications & Licensure
- NY State Medical License 1982 - Present
- CT State Medical License 2016 - 2025
- CA State Medical License 1988 - 2024
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 452 citationsUpdating the American Society of Clinical Oncology Value Framework: Revisions and Reflections in Response to Comments ReceivedLowell E. Schnipper, Nancy E. Davidson, Dana S. Wollins, Douglas W. Blayney, Adam P. Dicker
Journal of Clinical Oncology. 2016-09-27 - 654 citationsAmerican Society of Clinical Oncology Statement: A Conceptual Framework to Assess the Value of Cancer Treatment OptionsLowell E. Schnipper, Nancy E. Davidson, Dana S. Wollins, Courtney Tyne, Douglas W. Blayney
Journal of Clinical Oncology. 2015-06-22 - 128 citationsAssociation of Convalescent Plasma Therapy With Survival in Patients With Hematologic Cancers and COVID-19.Michael A. Thompson, Jeffrey P. Henderson, Pankil Shah, Samuel M. Rubinstein, Michael J. Joyner
JAMA Oncology. 2021-06-17
Press Mentions
- Various Cancer Treatment Drugs Experiencing Nationwide ShortageMay 22nd, 2023
- New ASCO Statement on the Importance of Phase I TrialsJanuary 10th, 2015
- These Experts Are Seeing Spikes in Drug ShortagesMay 31st, 2023
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: